event
Åpent møte
20
september 2022
Is your company US investor ready? In this “Reality Check", we invite you to engage with investors and experts for unfiltered and honest feedback.
Time: Tuesday, Sept 20th, 2022, 2:00 PM – 4:00 PM CET
Venue: Digital Meeting (link will be sent out to participants)
Norwegian health tech and life science companies aiming for US market entry face numerous challenges, with market failure most often related to gaps in information, awareness, or proper diligence in market dynamics and implementation. And while many of the top global investors in health tech and life science reside in the US, approaching US investors differs from the ways in which you interact with Norwegian or Nordic investors.
Is your company US investor ready?
In this “Reality Check – Are you US investor ready?”, USA Next invites you to engage with investors and experts for unfiltered and honest feedback. We first explore differences between Nordic and US investors, how and when to approach US investors, and what to prepare to get their attention. We will then send 3 selected companies into a “Reality Check”, where our investors and experts offer direct, actionable feedback to a pitch. At the end of the session, we will hold an open QA between the audience and panel, so please come with questions!
Agenda:
14.00 - 14.05 Introduction to the topic
14.05 - 14.30 PANEL discussion: Nordic vs. US Readiness – what is different
14.30 – 15.30 Reality Check – Is YOUR company US investor ready?
15.30 - 15.45 Audience QA to investors
Katherine Mellis, Hadean Ventures
Pekka Simula, Innovestor
Jonathan P. Gertler, BioVentures Medtech Funds
Kelsey Tsai, Sandbox Clinical Ventures
Supported by:
***
Relaterte dokumenter: